Published in JAMA on December 26, 1986
Epidemiology and risk factors for drug allergy. Br J Clin Pharmacol (2011) 1.44
Severe delayed-onset hypersensitivity reactions to amoxicillin in children. CMAJ (1989) 1.39
A review of adverse cutaneous drug reactions resulting from the use of interferon and ribavirin. Can J Gastroenterol (2009) 1.23
Justified concern or exaggerated fear: the risk of anaphylaxis in percutaneous treatment of cystic echinococcosis-a systematic literature review. PLoS Negl Trop Dis (2011) 1.16
Cutaneous reactions to drugs. An analysis of spontaneous reports in four Italian regions. Br J Clin Pharmacol (1999) 1.07
Adverse cutaneous drug reactions: Eight year assessment in hospitalized patients. J Res Med Sci (2014) 1.01
Drug Eruptions: An 8-year Study Including 106 Inpatients at a Dermatology Clinic in Turkey. Indian J Dermatol (2012) 1.01
Skin manifestations of drug allergy. Br J Clin Pharmacol (2011) 1.00
Update on the management of antibiotic allergy. Allergy Asthma Immunol Res (2010) 0.95
Chronic kidney disease in gout in a managed care setting. BMC Nephrol (2011) 0.93
Mucocutaneous manifestations of Dengue fever. Indian J Dermatol (2010) 0.92
Strategies for diagnosing and treating suspected acute bacterial sinusitis: a cost-effectiveness analysis. J Gen Intern Med (2001) 0.88
Allergic reactions to iodinated contrast media: premedication considerations for patients at risk. Emerg Radiol (2013) 0.88
Slow acetylator phenotype and genotype in HIV-positive patients with sulphamethoxazole hypersensitivity. Br J Clin Pharmacol (2003) 0.86
Rosacea-like facial rash related to metformin administration in a young woman. BMC Pharmacol Toxicol (2014) 0.85
Late adverse reactions to intravascular iodine based contrast media: an update. Eur Radiol (2011) 0.84
Clinical applications of drug desensitization in the Asia-Pacific region. Asia Pac Allergy (2011) 0.84
Drug reaction with eosinophilia and systemic symptoms syndrome (DRESS) syndrome associated with azithromycin presenting like septic shock: a case report. J Med Case Rep (2014) 0.82
Challenge Test Results in Patients With Suspected Penicillin Allergy, but No Specific IgE. Allergy Asthma Immunol Res (2011) 0.78
Skin reactions to co-trimoxazole. Infection (1987) 0.77
Adverse cutaneous drug eruptions: current understanding. Semin Immunopathol (2015) 0.76
Adverse drug reactions in an emergency medical dispatching centre. Eur J Clin Pharmacol (2014) 0.76
Cutaneous manifestations of infectious diseases: approach to the patient with fever and rash. Trans Am Clin Climatol Assoc (2001) 0.75
Drug Reaction with Eosinophilia and Systemic Symptoms: DRESS following Initiation of Oxcarbazepine with Elevated Human Herpesvirus-6 Titer. Case Rep Dermatol Med (2014) 0.75
A six-month prospective study to find out the treatment outcome, prognosis and offending drugs in toxic epidermal necrolysis from an urban institution in kolkata. Indian J Dermatol (2013) 0.75
Dermatomyositis and Paclitaxel-Induced Cutaneous Drug Eruption Associated with Metastatic Breast Cancer. J Breast Cancer (2015) 0.75
Principles of pharmacotherapy: III. Drug allergy. Anesth Prog (1989) 0.75
Identification of MHC Haplotypes Associated with Drug-induced Hypersensitivity Reactions in Cynomolgus Monkeys. Toxicol Pathol (2016) 0.75
Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs. Lancet (1994) 6.40
The Ikaros gene is required for the development of all lymphoid lineages. Cell (1994) 5.90
Histamine-2 receptor antagonists and gastric cancer. Epidemiology (1996) 5.43
Mumps, measles, and rubella vaccine and the incidence of autism recorded by general practitioners: a time trend analysis. BMJ (2001) 5.40
Antibiotics and risk of subsequent first-time acute myocardial infarction. JAMA (1999) 5.37
Antidepressants and suicide. BMJ (1995) 4.84
Multivitamin/folic acid supplementation in early pregnancy reduces the prevalence of neural tube defects. JAMA (1989) 4.52
Postmarketing follow-up at Group Health Cooperative of Puget Sound. Pharmacotherapy (1984) 4.39
Selective defects in the development of the fetal and adult lymphoid system in mice with an Ikaros null mutation. Immunity (1996) 3.91
HMG-CoA reductase inhibitors and the risk of fractures. JAMA (2000) 3.91
GCN4 protein, a positive transcription factor in yeast, binds general control promoters at all 5' TGACTC 3' sequences. Proc Natl Acad Sci U S A (1986) 3.68
The presynaptic particle web: ultrastructure, composition, dissolution, and reconstitution. Neuron (2001) 3.68
Risk of venous thromboembolism with cyproterone or levonorgestrel contraceptives. Lancet (2001) 3.48
Cigarette smoking and ulcerative colitis. N Engl J Med (1983) 3.47
Antipsychotic drug use and risk of first-time idiopathic venous thromboembolism: a case-control study. Lancet (2000) 3.35
The incidence of erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis. A population-based study with particular reference to reactions caused by drugs among outpatients. Arch Dermatol (1990) 3.32
Addiction rare in patients treated with narcotics. N Engl J Med (1980) 3.20
Efficacy and toxicity of heparin in relation to age and sex. N Engl J Med (1968) 2.99
Comprehensive drug surveillance. JAMA (1970) 2.92
The pathogenesis of oral lichen planus. Crit Rev Oral Biol Med (2002) 2.78
Drug surveillance utilizing nurse monitors. An epidemiological approach. Lancet (1966) 2.69
Replacement estrogens and endometrial cancer. N Engl J Med (1979) 2.65
Calcium-channel blockers and risk of cancer. Lancet (1997) 2.53
Drug rash with ampicillin and other penicillins. Lancet (1969) 2.50
Drugs--remarkably nontoxic. N Engl J Med (1974) 2.43
Acute respiratory-tract infections and risk of first-time acute myocardial infarction. Lancet (1998) 2.39
Venous thromboembolic disease and ABO blood type. A cooperative study. Lancet (1969) 2.38
Statin use and cancer risk in the General Practice Research Database. Br J Cancer (2004) 2.34
The discovery of drug-induced illness. N Engl J Med (1977) 2.29
Dexamethasone and dexamethasone-aspirin in the treatment of chronic rheumatoid arthritis. A controlled trial. Lancet (1965) 2.18
The incidence of breast cancer in the General Practice Research Database compared with national cancer registration data. Br J Cancer (2000) 2.17
Predictive values, relative risks, and overall benefits of high and low maternal serum alpha-fetoprotein screening in singleton pregnancies: new epidemiologic data. Am J Obstet Gynecol (1989) 2.12
Molecular modification of N-cadherin in response to synaptic activity. Neuron (2000) 2.02
Relation between smoking and age of natural menopause. Report from the Boston Collaborative Drug Surveillance Program, Boston University Medical Center. Lancet (1977) 2.00
Omeprazole, other antiulcer drugs and newly diagnosed gout. Br J Clin Pharmacol (1997) 1.99
Case-control studies in the evaluation of drug-induced illness. Am J Epidemiol (1978) 1.88
Antidepressant drugs and suicide. J Clin Psychopharmacol (1992) 1.80
Acute liver injury associated with nonsteroidal anti-inflammatory drugs and the role of risk factors. Arch Intern Med (1994) 1.79
Population-based study on incidence, risk factors, clinical complications and drug utilisation associated with influenza in the United Kingdom. Eur J Clin Microbiol Infect Dis (2000) 1.75
The epidemic of endometrial cancer: a commentary. Am J Public Health (1980) 1.74
Vaginal spermicides and congenital disorders. JAMA (1981) 1.74
Postmenopausal estrogen replacement therapy and the risk of developing systemic lupus erythematosus or discoid lupus. J Rheumatol (1998) 1.66
Coffee and myocardial infarction. N Engl J Med (1973) 1.66
The natural history of recurrent facial-oral infection with herpes simplex virus. J Infect Dis (1978) 1.65
The sunscreen and melanoma controversy. Arch Dermatol (1999) 1.64
Fatal drug reactions among medical inpatients. JAMA (1971) 1.64
The demand for eating disorder care. An epidemiological study using the general practice research database. Br J Psychiatry (1996) 1.63
The risk of venous thromboembolism in users of postcoital contraceptive pills. Contraception (1999) 1.62
Pregnancies and terminations after 1995 warning about third-generation oral contraceptives. Lancet (1998) 1.61
Evaluation of drug efficacy by a preference technic. N Engl J Med (1966) 1.60
Haemophilus influenzae vaccine. Br J Gen Pract (1995) 1.59
Functional cis-heterodimers of N- and R-cadherins. J Cell Biol (2000) 1.57
A review of epidemiologic research on drug-induced acute liver injury using the general practice research data base in the United Kingdom. Pharmacotherapy (1997) 1.55
Vasectomy and non-fatal myocardial infarction. Lancet (1981) 1.54
Drug-related deaths among medical inpatients. JAMA (1977) 1.53
First trimester topical tretinoin and congenital disorders. Lancet (1993) 1.45
Drug-induced gastrointestinal bleeding. Report from the Boston Collaborative Drug Surveillance Program, Boston University Medical Center. Lancet (1978) 1.45
Angiotensin-converting enzyme inhibitors, calcium channel blockers, and breast cancer. Arch Intern Med (2000) 1.44
Adverse drug reactions: the magnitude of the problem. J Allergy Clin Immunol (1984) 1.38
Incidence of first-time idiopathic seizures in users of tramadol. Pharmacotherapy (2000) 1.38
Intensive hospital monitoring study of intravenous cimetidine. Arch Intern Med (1986) 1.38
Temporal and regional variation in hysterectomy rates in the United States, 1970--1975. Am J Epidemiol (1979) 1.37
Tamoxifen and risk of idiopathic venous thromboembolism. Br J Clin Pharmacol (1998) 1.36
Optimization of 4-phenylamino-3-quinolinecarbonitriles as potent inhibitors of Src kinase activity. J Med Chem (2001) 1.36
Adverse reactions to trimethoprim-sulfamethoxazole in hospitalized patients. Rev Infect Dis (1982) 1.35
Cholestatic hepatitis associated with flucloxacillin. Med J Aust (1993) 1.34
First-trimester drug use and congenital disorders. JAMA (1981) 1.34
Physiology: does gut hormone PYY3-36 decrease food intake in rodents? Nature (2004) 1.34
Drug-induced anaphylaxis, convulsions, deafness, and extrapyramidal symptoms. Lancet (1977) 1.33
Acute adverse reactions attributed to allopurinol in hospitalised patients. Ann Rheum Dis (1981) 1.33
Correlation of lac operator DNA imino proton exchange kinetics with its function. Proc Natl Acad Sci U S A (1984) 1.32
Oral contraceptives and breast cancer. Am J Epidemiol (1980) 1.32
Assessment of adverse reactions within a drug surveillance program. JAMA (1968) 1.23
Cancer of the corpus uteri: increasing incidence in the United States, 1970--1975. Am J Epidemiol (1979) 1.22
Control of persistent ventricular ectopic beats by alprenolol, a new beta-adrenergic blocking agent. Am Heart J (1969) 1.21
Risk of idiopathic venous thromboembolism in users of progestagens alone. Lancet (1999) 1.20
Rates of cutaneous reactions to drugs. A report from the Boston Collaborative Drug Surveillance Program. JAMA (1976) 1.20
Computer analysis of epidemiologic data on effect of drugs on hospital patients. Public Health Rep (1969) 1.19
Use of selective serotonin reuptake inhibitors and risk of developing first-time acute myocardial infarction. Br J Clin Pharmacol (2001) 1.19
Inhibition of human melanoma growth and metastasis in vivo by anti-CD44 monoclonal antibody. Cancer Res (1994) 1.19
Possible molecular detent in the DNA structure at regulatory sequences. J Biomol Struct Dyn (1983) 1.16
Third-generation oral contraceptives and venous thrombosis. Lancet (1997) 1.16
Adverse reactions to co-trimoxazole in hospitalized medical patients. Am J Med Sci (1978) 1.15
Atracurium--a post-marketing surveillance study: U.K. study and discussion. Br J Anaesth (1989) 1.15
Appendectomy protects against ulcerative colitis. Epidemiology (1998) 1.15
Intracranial haemorrhage and use of selective serotonin reuptake inhibitors. Br J Clin Pharmacol (2000) 1.14
Non-steroidal anti-inflammatory drugs and hospital admission for perforated peptic ulcer. Lancet (1987) 1.14
Myocardial infarction and estrogen therapy in post-menopausal women. N Engl J Med (1976) 1.13
Oral contraceptives and nonfatal vascular disease. Obstet Gynecol (1985) 1.13
The turnover of microsomal reduced nicotinamide adenine dinucleotide phosphate-cytochrome c reductase in the livers of mice treated with phenobarbital. J Biol Chem (1966) 1.13
Risk of gynaecomastia associated with cimetidine, omeprazole, and other antiulcer drugs. BMJ (1994) 1.13
Vaginal spermicides and gonorrhea. JAMA (1982) 1.12
Statin use, hyperlipidaemia, and the risk of breast cancer. Br J Cancer (2002) 1.10
Diphtheria-tetanus-pertussis immunization and sudden infant death syndrome. Am J Public Health (1987) 1.09
The epidemiology o digoxin. A study in three Boston hospitals. J Chronic Dis (1969) 1.09
Risk of serious haematological toxicity with use of chloramphenicol eye drops in a British general practice database. BMJ (1998) 1.09
Non-pharmacological interventions to reduce the risk of diabetes in people with impaired glucose regulation: a systematic review and economic evaluation. Health Technol Assess (2012) 1.07
Pyloric stenosis and maternal Bendectin exposure. Am J Epidemiol (1984) 1.07
Replacement estrogens and breast cancer. Am J Epidemiol (1980) 1.06